Berres, Marie-Luise <br/><br/>
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.  [electronic resource] 

 -  The Journal of experimental medicine  Apr 2014 
 - 669-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-9538 
<br/><br/><label>Standard No.: </label>10.1084/jem.20130977  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD34--metabolism<br/>Antigens, Surface--metabolism<br/>Bone Marrow--pathology<br/>CD11c Antigen--metabolism<br/>Cell Differentiation<br/>Cell Lineage<br/>Child<br/>Child, Preschool<br/>Dendritic Cells--metabolism<br/>Female<br/>Genetic Predisposition to Disease<br/>Hematopoietic Stem Cells--metabolism<br/>Histiocytosis, Langerhans-Cell--blood<br/>Histocompatibility Antigens Class II--metabolism<br/>Humans<br/>Infant<br/>Lectins, C-Type--metabolism<br/>Male<br/>Mannose-Binding Lectins--metabolism<br/>Mice<br/>Mutation--genetics<br/>Phenotype<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Risk Factors<br/>Treatment Outcome